Service

 

Our (e)Books and (e)Journals

IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.

Service

 

Body Weight Has Surprising, Alarming Impact on Brain Function

August 5, 2020 - Amsterdam, NL and Costa Mesa, CA, USA – As a person's weight goes up, all regions of the brain go down in activity and blood flow, according to a new brain imaging study in the Journal of Alzheimer's Disease. One of the largest studies linking obesity with brain dysfunction, scientists analyzed over 35,000 functional neuroimaging scans using single-photon emission computerized tomography from more than 17,000 individuals to measure blood flow and brain activity.

August 5, 2020

The Outlook Is Encouraging: Researchers Evaluate a Pipeline of Clinical Trials Targeting Parkinson’s Disease

August 3, 2020 - Amsterdam, NL – A review of currently registered clinical trials of agents targeting Parkinson's disease (PD) reveals that there is a broad pipeline of both symptomatic and potentially disease-modifying therapies currently being evaluated. Investigators report that the outlook for patients is encouraging, given the wide range of therapeutics being clinically tested. They emphasize the importance of engaging the Parkinson's community in the research. Their analysis and results are published in the Journal of Parkinson's Disease.

August 3, 2020

How Rehabilitation Impacts Research and Care of Patients with Cerebral Palsy

August 3, 2020 - Amsterdam, NL – Cerebral palsy (CP) is one of the most common developmental movement disorders in children. In this special issue of the Journal of Pediatric Rehabilitation Medicine (JPRM), experts present advancements made by rehabilitation medicine in the care of patients with CP, improving quality of life and research.

August 3, 2020

Memory Loss Reversed or Abated in those with Cognitive Decline

July 31, 2020 - Sonoma, CA, USA – Affirmativ Health sought to determine whether a comprehensive and personalized program, designed to mitigate risk factors of Alzheimer's disease could improve cognitive and metabolic function in individuals experiencing cognitive decline. Findings published in the Journal of Alzheimer's Disease Reports provided evidence that this approach can improve risk factor scores and stabilize cognitive function.

July 31, 2020